Developing Growth Fund
Daily price w/o sales charge as of 01/26/2023
$18.27
$0.22
YTD Returns w/o sales charge as of 01/26/2023
7.79%
Please click here for performance current to the most recent quarter-end and month-end.
Summary
Summary
Fund Basicsas of 12/30/2022
- Total Net Assets
- $2.52 B
- Inception Date
- 10/10/1973
- Dividend Frequency
- Annually
- Number of Holdings
- 92
- Minimum Initial Investment
- $1,000+
Expense Ratioas of 12/31/2022
Fund Expense Ratio :
0.94%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 10/10/1973 |
|---|
| w/o sales charge | -36.09% | -36.09% | 2.40% | 8.28% | 10.77% | 10.29% |
| Lipper Category Avg. Small-Cap Growth Funds | -26.66% | -26.66% | 3.55% | 6.14% | 9.96% | - |
| Russell 2000® Growth Index | -26.36% | -26.36% | 0.65% | 3.51% | 9.20% | - |
| w/ sales charge | -39.77% | -39.77% | 0.39% | 7.01% | 10.12% | 10.15% |
Fund Expense Ratio :
0.94%
Fund Expense Ratio :
0.94%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 10/10/1973 |
|---|
| w/o sales charge | -36.09% | -36.09% | 2.40% | 8.28% | 10.77% | 10.29% |
| Lipper Category Avg. Small-Cap Growth Funds | -26.66% | -26.66% | 3.55% | 6.14% | 9.96% | - |
| Russell 2000® Growth Index | -26.36% | -26.36% | 0.65% | 3.51% | 9.20% | - |
| w/ sales charge | -39.77% | -39.77% | 0.39% | 7.01% | 10.12% | 10.15% |
Fund Expense Ratio :
0.94%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
TEN LARGEST HOLDINGS as of 12/30/2022View Portfolio
| Holding | Assets |
|---|---|
| Calix Inc | 2.9% |
| Crocs Inc | 2.7% |
| Krystal Biotech Inc | 2.3% |
| Inspire Medical Systems Inc | 2.1% |
| Xenon Pharmaceuticals Inc | 2.1% |
| Clear Secure Inc | 2.0% |
| Cytokinetics Inc | 2.0% |
| Planet Fitness Inc | 2.0% |
| Apellis Pharmaceuticals Inc | 1.8% |
| Comfort Systems USA Inc | 1.8% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 12/30/2022View Portfolio
| Sector | Weighting |
|---|
| Sector | Weighting |
|---|---|
| Communication Services | |
| Real Estate | |
| Utilities | |
| Consumer Discretionary | |
| Consumer Staples | |
| Energy | |
| Financials | |
| Health Care | |
| Industrials | |
| Information Technology | |
| Materials |
INVESTMENT TEAM
Your Representative
To contact your representative, enter your zip code and select your channel below.
Performance
Performance
Fund Expense Ratio :
0.94%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 10/10/1973 |
|---|
| w/o sales charge | -36.09% | -36.09% | 2.40% | 8.28% | 10.77% | 10.29% |
| Lipper Category Avg. Small-Cap Growth Funds | -26.66% | -26.66% | 3.55% | 6.14% | 9.96% | - |
| Russell 2000® Growth Index | -26.36% | -26.36% | 0.65% | 3.51% | 9.20% | - |
| w/ sales charge | -39.77% | -39.77% | 0.39% | 7.01% | 10.12% | 10.15% |
Fund Expense Ratio :
0.94%
Fund Expense Ratio :
0.94%
| YTD | 1-YR | 3-YR | 5-YR | 10-YR | Since Inception 10/10/1973 |
|---|
| w/o sales charge | -36.09% | -36.09% | 2.40% | 8.28% | 10.77% | 10.29% |
| Lipper Category Avg. Small-Cap Growth Funds | -26.66% | -26.66% | 3.55% | 6.14% | 9.96% | - |
| Russell 2000® Growth Index | -26.36% | -26.36% | 0.65% | 3.51% | 9.20% | - |
| w/ sales charge | -39.77% | -39.77% | 0.39% | 7.01% | 10.12% | 10.15% |
Fund Expense Ratio :
0.94%
Returns with sales charges reflect a maximum sales charge of 5.75%.
The performance quoted represents past performance, which is no indication of future results. Current performance may be higher or lower than the performance data quoted. Returns shown include the reinvestment of all distributions. Returns shown at net asset value do not reflect the current maximum sales charge, had the sales charge been included, returns would have been lower. The investment return and principal value of an investment will fluctuate so that shares, on any given day or when redeemed, may be worth more or less than the original cost. Therefore, there can be no assurance for future results.
| Year | Fund Returns | Russell 2000® Growth Index |
|---|
| 2022 | -36.09% | -26.36% |
| 2021 | -2.66% | 2.83% |
| 2020 | 72.57% | 34.63% |
| 2019 | 31.91% | 28.48% |
| 2018 | 5.09% | -9.31% |
| 2017 | 29.92% | 22.17% |
| 2016 | -2.71% | 11.32% |
| 2015 | -8.90% | -1.38% |
| 2014 | 3.25% | 5.60% |
| 2013 | 57.19% | 43.30% |
| 2012 | 10.39% | - |
| 2011 | -1.66% | - |
| 2010 | 36.54% | - |
| 2009 | 47.03% | - |
| 2008 | -47.50% | - |
| 2007 | 35.83% | - |
| 2006 | 12.45% | - |
| 2005 | 11.87% | - |
| 2004 | 6.00% | - |
| 2003 | 40.06% | - |
| Year | Q1 | Q2 | Q3 | Q4 | Yearly Returns |
|---|
| 2023 | - | - | - | - | 7.79% |
| 2022 | -19.27% | -21.16% | 0.59% | -0.18% | -36.09% |
| 2021 | 1.64% | 2.87% | -3.66% | -3.35% | -2.66% |
| 2020 | -16.91% | 40.59% | 15.92% | 27.45% | 72.57% |
| 2019 | 27.01% | 9.09% | -11.35% | 7.39% | 31.91% |
| 2018 | 7.16% | 14.97% | 12.18% | -23.96% | 5.09% |
| 2017 | 8.36% | 4.06% | 7.07% | 7.61% | 29.92% |
| 2016 | -10.30% | 2.24% | 10.87% | -4.32% | -2.71% |
| 2015 | 7.12% | 2.61% | -15.70% | -1.68% | -8.90% |
| 2014 | 1.67% | 0.15% | -5.75% | 7.59% | 3.25% |
| 2013 | 13.50% | 10.00% | 18.78% | 6.00% | 57.19% |
| 2012 | 12.16% | -2.68% | 5.55% | -4.19% | 10.39% |
| 2011 | 10.23% | 1.49% | -20.86% | 11.06% | -1.66% |
| 2010 | 8.21% | -7.94% | 16.47% | 17.68% | 36.54% |
| 2009 | -2.17% | 24.37% | 14.25% | 5.76% | 47.03% |
| 2008 | -21.82% | 6.65% | -11.81% | -28.60% | -47.50% |
| 2007 | 4.65% | 13.60% | 9.82% | 4.04% | 35.83% |
| 2006 | 15.98% | -6.23% | -6.80% | 10.93% | 12.45% |
| 2005 | -5.91% | 5.82% | 9.60% | 2.52% | 11.87% |
| 2004 | 2.00% | 0.20% | -7.05% | 11.58% | 6.00% |
| 2003 | -3.27% | 21.33% | 9.79% | 8.70% | 40.06% |
| 2002 | 0.07% | -11.90% | -23.81% | 4.90% | -29.54% |
| 2001 | -17.44% | 16.01% | -22.68% | 25.62% | -6.98% |
| 2000 | 3.52% | -13.67% | -0.56% | -7.37% | -17.69% |
| 1999 | 1.42% | 11.69% | -3.37% | 26.23% | 38.16% |
| 1998 | 11.49% | -2.94% | -22.00% | 28.29% | 8.27% |
| 1997 | -2.88% | 17.68% | 21.77% | -6.03% | 30.78% |
| 1996 | 8.18% | 8.18% | -2.85% | 7.46% | 22.19% |
| 1995 | 6.04% | 19.02% | 15.90% | -0.42% | 45.66% |
| 1994 | 0.16% | -8.07% | 10.54% | 4.34% | 6.20% |
| 1993 | -0.67% | 1.03% | 8.15% | 3.76% | 12.62% |
| 1992 | -2.92% | -13.34% | 5.39% | 9.32% | -3.06% |
| 1991 | 29.96% | -5.07% | 9.77% | 15.46% | 56.36% |
| 1990 | 1.18% | 11.38% | -24.62% | 10.17% | -6.41% |
| 1989 | 3.04% | 1.70% | 8.07% | 0.77% | 14.12% |
| 1988 | 8.71% | 2.49% | -4.04% | -3.23% | 3.45% |
| 1987 | 23.22% | -1.54% | 5.33% | -21.15% | 0.76% |
| 1986 | 12.02% | 1.82% | -18.44% | 7.95% | 0.42% |
| 1985 | 9.91% | -2.42% | -9.28% | 18.16% | 14.96% |
| 1984 | -15.56% | -5.27% | 1.63% | -4.54% | -22.39% |
| 1983 | 19.37% | 16.69% | -4.44% | -6.33% | 24.68% |
| 1982 | -11.29% | 1.28% | 11.66% | 29.18% | 29.58% |
| 1981 | 6.38% | 7.72% | -18.09% | 14.79% | 7.74% |
| 1980 | -8.32% | 13.37% | 24.22% | 5.17% | 35.80% |
| 1979 | 11.23% | 3.38% | 10.21% | 1.23% | 28.29% |
| 1978 | 12.74% | 18.50% | 11.85% | -9.31% | 35.51% |
| 1977 | -5.21% | 6.36% | 3.99% | 7.90% | 13.12% |
| 1976 | 25.90% | -5.36% | -5.21% | 5.87% | 19.57% |
| 1975 | 36.09% | 17.79% | -12.76% | -0.65% | 38.93% |
| 1974 | 2.02% | -14.31% | -23.96% | -3.25% | -35.69% |
| 1973 | - | - | - | - | -9.00% |
Performance is shown for each quarter and each calendar year. Past performance is no guarantee of future results.
Growth of $10,000 as of 07/31/2021
The chart begins on the Fund's inception date of 10/10/1973.
Based on a hypothetical Class A share investment of $10,000 on 10/10/1973 without sales charge and includes the reinvestment of all distributions.
NAV Historical Prices
| Date | Net Asset Value |
|---|
Portfolio
Portfolio
| Holding | Sector | Assets |
|---|
| Calix Inc | Information Technology | 2.9% |
| Crocs Inc | Consumer Discretionary | 2.7% |
| Krystal Biotech Inc | Health Care | 2.3% |
| Inspire Medical Systems Inc | Health Care | 2.1% |
| Xenon Pharmaceuticals Inc | Health Care | 2.1% |
| Clear Secure Inc | Information Technology | 2.0% |
| Cytokinetics Inc | Health Care | 2.0% |
| Planet Fitness Inc | Consumer Discretionary | 2.0% |
| Apellis Pharmaceuticals Inc | Health Care | 1.8% |
| Comfort Systems USA Inc | Industrials | 1.8% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
| Holding | Sector | Assets |
|---|
| Shockwave Medical Inc | Health Care | 2.9% |
| Calix Inc | Information Technology | 2.6% |
| Lantheus Holdings Inc | Health Care | 2.6% |
| Axonics Inc | Health Care | 2.5% |
| Intra-Cellular Therapies Inc | Health Care | 2.5% |
| Cytokinetics Inc | Health Care | 2.3% |
| Karuna Therapeutics Inc | Health Care | 2.2% |
| Livent Corp | Materials | 2.1% |
| Apellis Pharmaceuticals Inc | Health Care | 2.1% |
| Krystal Biotech Inc | Health Care | 2.0% |
| Sarepta Therapeutics Inc | Health Care | 2.0% |
| Inspire Medical Systems Inc | Health Care | 1.9% |
| CyberArk Software Ltd | Information Technology | 1.9% |
| Chart Industries Inc | Industrials | 1.8% |
| Xenon Pharmaceuticals Inc | Health Care | 1.7% |
| iRhythm Technologies Inc | Health Care | 1.7% |
| Clear Secure Inc | Information Technology | 1.7% |
| Ameresco Inc | Industrials | 1.6% |
| Clean Harbors Inc | Industrials | 1.6% |
| Glaukos Corp | Health Care | 1.6% |
| Comfort Systems USA Inc | Industrials | 1.5% |
| World Wrestling Entertainment Inc | Communication Services | 1.5% |
| HealthEquity Inc | Health Care | 1.5% |
| RBC Bearings Inc | Industrials | 1.5% |
| Tetra Tech Inc | Industrials | 1.4% |
| Inari Medical Inc | Health Care | 1.3% |
| Parsons Corp | Industrials | 1.3% |
| Balchem Corp | Materials | 1.2% |
| Crocs Inc | Consumer Discretionary | 1.2% |
| Axon Enterprise, Inc. | Industrials | 1.2% |
| Rambus Inc | Information Technology | 1.1% |
| Duolingo Inc | Consumer Discretionary | 1.1% |
| Ventyx Biosciences Inc | Health Care | 1.1% |
| Global-e Online Ltd | Consumer Discretionary | 1.1% |
| AeroVironment Inc | Industrials | 1.1% |
| Evoqua Water Technologies Corp | Industrials | 1.1% |
| Globant SA | Information Technology | 1.1% |
| Sweetgreen Inc | Consumer Discretionary | 1.0% |
| Endava PLC | Information Technology | 1.0% |
| Cerevel Therapeutics Holdings Inc | Health Care | 1.0% |
| Jamf Holding Corp | Information Technology | 1.0% |
| Sprout Social Inc | Information Technology | 0.9% |
| Inter Parfums Inc | Consumer Staples | 0.9% |
| Array Technologies Inc | Industrials | 0.9% |
| Diodes Inc | Information Technology | 0.9% |
| Flywire Corp | Information Technology | 0.9% |
| Deckers Outdoor Corp | Consumer Discretionary | 0.9% |
| Glacier Bancorp Inc | Financials | 0.8% |
| Five9 Inc | Information Technology | 0.8% |
| Range Resources Corp | Energy | 0.8% |
| ZipRecruiter Inc | Communication Services | 0.8% |
| HashiCorp Inc | Information Technology | 0.8% |
| Cabot Corp | Materials | 0.8% |
| FTI Consulting Inc | Industrials | 0.8% |
| Planet Fitness Inc | Consumer Discretionary | 0.8% |
| Silvergate Capital Corp | Financials | 0.8% |
| Evolent Health Inc | Health Care | 0.8% |
| Procore Technologies Inc | Information Technology | 0.7% |
| Celsius Holdings Inc | Consumer Staples | 0.7% |
| Gitlab Inc | Information Technology | 0.7% |
| Applied Industrial Technologies Inc | Industrials | 0.7% |
| Gogo Inc | Communication Services | 0.7% |
| BJ's Wholesale Club Holdings Inc | Consumer Staples | 0.6% |
| Mirati Therapeutics Inc | Health Care | 0.6% |
| TransMedics Group Inc | Health Care | 0.6% |
| Impinj Inc | Information Technology | 0.6% |
| Saia Inc | Industrials | 0.5% |
| CEVA Inc | Information Technology | 0.5% |
| AvidXchange Holdings Inc | Information Technology | 0.5% |
| Valmont Industries Inc | Industrials | 0.5% |
| Rush Enterprises Inc | Industrials | 0.5% |
| Texas Roadhouse Inc | Consumer Discretionary | 0.5% |
| PowerSchool Holdings Inc | Consumer Discretionary | 0.5% |
| SentinelOne Inc | Information Technology | 0.5% |
| Legend Biotech Corp | Health Care | 0.5% |
| Piper Sandler Cos | Financials | 0.5% |
| Silicon Motion Technology Corp | Information Technology | 0.5% |
| Wingstop Inc | Consumer Discretionary | 0.5% |
| Tenable Holdings Inc | Information Technology | 0.5% |
| Natera Inc | Health Care | 0.5% |
| Topgolf Callaway Brands Corp | Consumer Discretionary | 0.5% |
| Figs Inc | Health Care | 0.5% |
| Driven Brands Holdings Inc | Industrials | 0.5% |
| Talos Energy Inc | Energy | 0.5% |
| Qualtrics International Inc | Information Technology | 0.4% |
| Cactus Inc | Energy | 0.4% |
| MELI Kaszek Pioneer Corp | Undefined | 0.4% |
| indie Semiconductor Inc | Information Technology | 0.4% |
| Bumble Inc | Communication Services | 0.4% |
| WEX Inc | Information Technology | 0.3% |
| Matador Resources Co | Energy | 0.2% |
Aggregate holdings are updated monthly, 30 days after month end. Aggregate holdings are presented to illustrate examples of the securities that the Fund has bought and the diversity of the areas in which the Fund may invest, and may not be representative of the Fund's current or future investments. The figures presented are as of the date shown and may change at any time.
Sector Allocationas of 12/30/2022
| Sector | Weighting | Fund Change from Previous Quarter |
|---|
| Sector | Weighting | Fund Change from Previous Quarter |
|---|---|---|
| Communication Services |
 1.4%
|
|
| Real Estate | 0.0% | |
| Utilities | 0.0% | |
| Consumer Discretionary |
4.2%
|
|
| Consumer Staples |
0.1%
|
|
| Energy |
1.3%
|
|
| Financials |
0.7%
|
|
| Health Care |
6.8%
|
|
| Industrials |
0.4%
|
|
| Information Technology |
5.1%
|
|
| Materials |
1.3%
|
Portfolio Details as of 12/30/2022
- Total Net Assets
- $2.52 B
- Number of Holdings
- 92
- Weighted Average Market Cap.
- 4.8 B
- P/B Ratio
- 5.4x
- P/E Ratio
- 25.0x
To view definitions for the above Portfolio Details, Click here.
Market Capitalization Breakdown - Morningstar separates stock portfolio holdings into five market-capitalization groups: Giant, Large, Mid, Small, and Micro. Of the 5000 largest domestic stocks in their equities database, the top 1% are categorized as Giant, the next 4% are Large, the next 15% are Mid, the next 30% are Small, and the remaining 50% are Micro. Stocks outside of the largest 5000 are also classified as Micro.
Weighted Average Market Cap - The average market capitalization of all companies held in the portfolio with each company weighted according to its percent held in the portfolio. The result is based upon a weighted average of the securities held in the fund.
P/B Ratio - A ratio that helps determine whether a stock is undervalued or overvalued. It is calculated by dividing a stock's price per share by its book value per share. The result is based upon a weighted average of the securities held in the fund.
P/E Ratio - Is the weighted average of each holding's P/E ratio (price of a stock divided by its earnings per share). The result is based upon a weighted average of the securities held in the fund.
Portfolio Turnover - This is a measure of the Fund’s trading activity which is computed by taking the lesser of purchases or sales divided by average monthly market value, excluding short-term investments. The resulting percentage represents the percentage of the portfolio’s holdings that have changed over the past year.
Contributors & Detractors as of 12/30/2022
Contributors
| Holding | Contribution |
|---|---|
| Crocs Inc | 0.9% |
| Inspire Med Sys Inc | 0.6% |
| Axon Enterprise Inc | 0.5% |
| Rambus Inc | 0.5% |
| Transmedics Group Inc | 0.4% |
Detractors
| Holding | Contribution |
|---|---|
| Shockwave Med Inc | -0.6% |
| Sweetgreen Inc | -0.5% |
| Chart Industries, Inc. | -0.5% |
| Apellis Pharmaceuticals | -0.5% |
| Lantheus Hldgs Inc | -0.5% |
% Contribution reflects the effect of the individual stock's performance on the Fund's overall performance for the period. Individual holdings and their effect on Fund performance may change significantly over time. Investors should consider the overall performance of the Fund before making a decision on whether or not to invest in the Fund.
Attribution Analysis
| Developing Growth Fund | Benchmark | Variance | |||||
|---|---|---|---|---|---|---|---|
| Sector | Avg. Weight | Base Return | Avg. Weight | Base Return | Stock Selection | Group Weight | Total |
The total base return displayed for the Fund does not capture daily cash flow and trading activity and therefore is subject to reasonable variance from the Fund's actual return. Please refer to the Fund's performance results for longer-term returns. The Fund is actively managed and portfolio characteristics, such as individual holdings and sector weightings, may change significantly over time.
Source: Wilshire Attribution Software. GICS sector classification; non-GICS securities classified by Lord Abbett. Sectors may include many industries.
Dividends & Cap Gains
Dividends & Cap Gains
Dividend Payments
- YTD Dividends Paidas of 01/26/2023
- $0
- Dividend Frequency
- Annually
| Record Date | Ex-Dividend Date | Reinvest & Payable Date | Dividend | Reinvest Price |
|---|---|---|---|---|
| 02/14/1997 | 02/18/1997 | 03/03/1997 | $0.00000 |
Upcoming Dividend Payment Dates
This section lists all anticipated Income and Capital Gain distribution dates and any actual distributions are subject to adequacy of earnings and must be approved by the Board of Directors/Trustees. Please note that dates are subject to change.
| Record Date | Ex-Dividend Date | Reinvest & Payable Date |
|---|---|---|
| 11/20/2023 | 11/21/2023 | 11/21/2023 |
Capital Gains Distributions
| Record Date | Reinvest & Payable Date | Long-term | Short-term * | Total | Reinvest Price |
|---|---|---|---|---|---|
| 11/22/2021 | 11/23/2021 | $3.3406 | - | $3.3406 | $27.44 |
Taxed as ordinary income
Lord Abbett does not provide tax advice. It is strongly recommended that you discuss the impact of dividends and distributions with your tax advisor.
Fees & Expenses
Fees & Expenses
Sales Charge Schedule as of 01/26/2023
| Sales Charge | Dealer's Concession | Prices at Breakpoint | |
|---|---|---|---|
| Less than $50,000 | 5.75% | 5.00% | $19.38 |
| $50,000 to $99,999 | 4.75% | 4.00% | $19.18 |
| $100,000 to $249,999 | 3.95% | 3.25% | $19.02 |
| $250,000 to $499,999 | 2.75% | 2.25% | $18.79 |
| $500,000 to $999,999 | 1.95% | 1.75% | $18.63 |
| $1,000,000 to $5,000,000 | 0.00% | 1.00% | $18.27 |
The 12b-1 trail commission is 0.15% (accrues immediately) for all fixed-income and municipal income funds.
Class A shares purchased without a sales charge (commissionable NAV) will be subject to a CDSC of 1% if they are redeemed before the first day of the month in which the one-year anniversary of the purchase falls.
Expense Ratioas of 12/31/2022
Fund Documents
Fund Documents
Download fund documents & literature, create email subscriptions, and place direct mail order
|
0Documents selected
|
Order | ||||
|---|---|---|---|---|---|
| n/a |
Portfolio Holdings 1Q
Publish Date:11/03/2015
|
||||
| n/a |
Portfolio Holdings 3Q
Publish Date:11/03/2015
|
||||
|
Summary Prospectus
Publish Date:11/03/2015
|
|||||
| n/a |
Statutory Prospectus
Publish Date:11/03/2015
|
||||
|
SAI
Publish Date:11/03/2015
|
|||||
|
Annual Report
Publish Date:11/03/2015
|
|||||
|
Semi-Annual Report
Publish Date:11/03/2015
|
|||||
|
Fact Sheet
Publish Date:11/03/2015
|
|||||
|
Commentary
Publish Date:11/03/2015
|
|||||
|
Fund Story
Publish Date:11/03/2015
|
|||||